Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Histologic Type × Diphenhydramine × Clear all

Sponsor

Conditions

Vomiting 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasms 2 Nausea 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Hairy Cell 2 Leukemia 2 Kidney Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma in Situ 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rectal Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Nausea and Vomiting 1 Philadelphia Chromosome 1 Pathologic Complete Response 1 Papillomavirus Infections 1 Oncology Patients Receiving Chemotherapy 1

Interventions

ponatinib 4 Rituximab 3 Gemcitabine 3 130-nm albumin-bound paclitaxel 3 pralsetinib 2 pembrolizumab 2 napabucasin 2 Vincristine 2 Prednisone 2 Irinotecan 2 Imatinib Mesylate 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Brentuximab Vedotin 2 tetulomab tetraxetan lu-177 1 pamiparib 1 nirogacestat 1 nilotinib 1 ibritumomab tiuxetan 1 bosutinib 1 blinatumomab 1 Vorinostat 1 Temozolomide 1 Radiation 1 Pemetrexed 1 Papanicolaou Test 1 Paclitaxel 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡